AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Avita Therapeutics

2.790

-0.030-1.06%

Volume:571.36K

Turnover:1.58M

Market Cap:429.33M

PE:-0.17

High:2.800

Open:2.780

Low:2.720

Close:2.820

52wk High:2.860

52wk Low:1.000

Shares:153.88M

Float Shares:5.34M

Volume Ratio:0.67

T/O Rate:10.69%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-16.088

EPS(LYR):-19.466

ROE:-1746.27%

ROA:-41.56%

PB:-11.05

PE(LYR):-0.14

Loading ...

Overview Company News Filings

Avita Medical Says Clinical Study for Biosynthetic Wound Matrix Meets Primary Endpoint

MT Newswires Live

Avita Medical Reports Encouraging UK Evaluation of Wound Care System

MT Newswires Live

Avita Medical Posts Narrower Q1 Loss, Higher Revenue; Reaffirms Full-Year 2026 Outlook

MT Newswires Live

Stock Track | Avita Therapeutics Soars 5.35% Intraday on Leadership Appointments

Avita Medical Appoints CEO, Chair

MT Newswires Live

Avita Medical Says Wound Care System Preparation Method Receives Regulatory Approval in Australia, New Zealand

MT Newswires Live

Stock Track | Avita Therapeutics Soars 14.18% Intraday on Positive Interim Wound Care Study Results

Avita Medical Reports Positive Interim Results From Cohealyx-I Wound Care Study

MT Newswires Live

Avita Medical Secures Nearly $26 Million US Government Deal

MT Newswires Live

Avita Medical Files Shelf Registration Statement With US SEC; Shares Up 3%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/AVH.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AVH.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVH.AU\",,,,,undefined,":{"symbol":"AVH.AU","market":"AU","secType":"STK","nameCN":"Avita Therapeutics","latestPrice":2.79,"timestamp":1787292720000,"preClose":2.82,"halted":0,"volume":571356,"delay":0,"changeRate":-0.010638297872340358,"nameEN":"Avita Therapeutics","floatShares":5344505,"shares":153883445,"eps":-16.087768940979487,"marketStatus":"Market Closed","change":-0.03,"latestTime":"08-21 16:12:00 AEST","open":2.78,"high":2.8,"low":2.72,"amount":1579066,"amplitude":0.028369,"askPrice":2.79,"askSize":108823,"bidPrice":2.72,"bidSize":2182,"shortable":3,"etf":0,"ttmEps":-16.087768940979487,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"adrRate":8,"exchange":"ASX","adjPreClose":2.82,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":0.6722722694778811,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"AVH.AU","preClose":2.82,"auctionPrice":2.79,"auctionVolume":12627,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292600775}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVH.AU\",,,,,undefined,":{"symbol":"AVH.AU","floatShares":5344505,"roa":"-41.56%","roe":"-1746.27%","lyrEps":-19.466109,"volumeRatio":0.6722722694778811,"shares":153883445,"dividePrice":0,"high":2.8,"amplitude":0.028369,"preClose":2.82,"low":2.72,"week52Low":1,"pbRate":"-11.05","psRate":"4.07","week52High":2.86,"institutionHeld":0,"latestPrice":2.79,"committee":-0.960686,"eps":-16.087768940979487,"divideRate":0,"volume":571356,"delay":0,"ttmEps":-16.087768940979487,"open":2.78,"prevYearClose":1.05,"prevWeekClose":2.21,"prevMonthClose":1.295,"prevQuarterClose":1.2,"fiveDayClose":2.21,"twentyDayClose":1.315,"sixtyDayClose":1.14},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVH.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-08-07","symbol":"AVH.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1786024800000,"reportTimeType":"","actualEps":null},{"market":"AU","date":"2026-05-15","symbol":"AVH.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778767200000,"reportTimeType":"pre","actualEps":null},{"date":"2023-08-10","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1691625600000,"name":null,"time":"","dateTimestamp":1691589600000,"actualEps":null},{"date":"2023-05-11","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1683763200000,"name":null,"time":"","dateTimestamp":1683727200000,"actualEps":null},{"date":"2023-02-23","symbol":"AVH.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1677106800000,"name":null,"time":"","dateTimestamp":1677070800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVH.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVH.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660186464","title":"Avita Medical Says Clinical Study for Biosynthetic Wound Matrix Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2660186464","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660186464?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:54","pubTimestamp":1787097259,"startTime":"0","endTime":"0","summary":"Avita Medical  said its multicenter, randomized controlled clinical study for PermeaDerm, a biosynthetic wound matrix, met its primary endpoint, showing statistically significant superiority for mean cost per percent total body surface area treated, according to a Wednesday Australian bourse filing.The study enrolled 40 patients across 11 US burn centers, with wounds of up to 30% total body surface area. After excision, patients were randomized to receive either PermeaDerm or cadaveric allograft during the temporization period before definitive split-thickness skin grafting.Mean treatment cost was AU$148.70 for every 1% total body surface area treated with PermeaDerm, compared with AU$497.10 for allograft, representing a savings of around AU$348 per percent total body surface area.Around 94% of patients treated with PermeaDerm achieved at least 95% graft take one week following autografting, comparable to allograft, and all patients in both groups achieved 95% or greater wound healing ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","AVH.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644032803","title":"Avita Medical Reports Encouraging UK Evaluation of Wound Care System","url":"https://stock-news.laohu8.com/highlight/detail?id=2644032803","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644032803?lang=en_us&edition=fundamental","pubTime":"2026-06-19 07:33","pubTimestamp":1781825630,"startTime":"0","endTime":"0","summary":"Avita Medical  said its Recell GO wound care system was successfully evaluated in the UK, with investigators reporting healing and complete graft take across a range of burn and reconstructive procedures, according to a late Thursday statement.The medical system prepares a patient's own skin cells into a liquid that can be sprayed directly onto wounds to promote healing.Recell data presented during the British Burn Association's annual meeting also pointed to workflow benefits, including reduced procedural variability, improved consistency of cell preparation, and enhanced operating room efficiency, the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","AVH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635793587","title":"Avita Medical Posts Narrower Q1 Loss, Higher Revenue; Reaffirms Full-Year 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2635793587","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635793587?lang=en_us&edition=fundamental","pubTime":"2026-05-15 11:21","pubTimestamp":1778815269,"startTime":"0","endTime":"0","summary":"Avita Medical  reported Friday a March quarter net loss of $0.35 per share, compared with $0.53 a year earlier.Revenue for the three months ended March 31 was $19.3 million, compared with $18.5 million a year earlier.The company reaffirmed its full-year guidance, with revenue expected in the range of $80 million to $85 million.Its shares rose 1% in recent trading on Friday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","AVH.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147588160","title":"Stock Track | Avita Therapeutics Soars 5.35% Intraday on Leadership Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=1147588160","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147588160?lang=en_us&edition=fundamental","pubTime":"2026-05-01 08:11","pubTimestamp":1777594292,"startTime":"0","endTime":"0","summary":"Avita Therapeutics' stock surged 5.35% during intraday trading on Friday, following the announcement of key leadership changes at the company.The medical technology firm appointed Cary Vance as its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632693889","title":"Avita Medical Appoints CEO, Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2632693889","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632693889?lang=en_us&edition=fundamental","pubTime":"2026-05-01 07:51","pubTimestamp":1777593098,"startTime":"0","endTime":"0","summary":"Avita Medical  has appointed Cary Vance as chief executive, effective immediately, according to a Friday Australian bourse filing.Vance has been acting as interim CEO since October 2025, per the filing.The company also appointed Jan Stern Reed as chair with immediate effect, the filing added.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","AVH.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631867579","title":"Avita Medical Says Wound Care System Preparation Method Receives Regulatory Approval in Australia, New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2631867579","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631867579?lang=en_us&edition=fundamental","pubTime":"2026-04-30 08:42","pubTimestamp":1777509752,"startTime":"0","endTime":"0","summary":"Avita Medical  said its RECELL GO wound care system preparation method received regulatory clearance in Australia and New Zealand, allowing for commercialization in both markets for burn and acute wound treatment, according to a Thursday Australian bourse filing.It secured certification from Australia's Therapeutic Goods Administration and was listed on New Zealand's Web Assisted Notification of Devices database by Medsafe.RECELL GO combines a reusable, electricity-powered RECELL processing device with a single-use RECELL preparation kit, with one such kit capable of treating wounds up to 1,920 square centimeters, per the filing.Its exclusive distribution partner in Australia and New Zealand, Revolution Surgical, expects to begin the commercial launch within the coming weeks.Its shares rose over 2% in recent trading on Thursday.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NZ50G.NZ","BK7067","T10G.NZ","XAO.AU","AVH.AU","XJO.AU","XKO.AU","NZ20C.NZ","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135277977","title":"Stock Track | Avita Therapeutics Soars 14.18% Intraday on Positive Interim Wound Care Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1135277977","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135277977?lang=en_us&edition=fundamental","pubTime":"2026-04-15 08:02","pubTimestamp":1776211369,"startTime":"0","endTime":"0","summary":"Avita Therapeutics' stock soared 14.18% intraday following the release of positive interim data from a key clinical study.The surge comes after the company reported interim results from its...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AVH.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627856478","title":"Avita Medical Reports Positive Interim Results From Cohealyx-I Wound Care Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2627856478","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627856478?lang=en_us&edition=fundamental","pubTime":"2026-04-15 07:34","pubTimestamp":1776209656,"startTime":"0","endTime":"0","summary":"Avita Medical  said interim results from its Cohealyx-I multi-center study showed a reduction of nearly 20 days in the mean time to skin grafting, at 13.6 days compared with a 33.2-day real-world benchmark, for patients with full-thickness wounds, according to a Wednesday Australian bourse filing.The study's primary endpoint is time to autografting, and the secondary endpoints include wound healing and safety outcomes, per the filing.The company said the interim analysis of 40 patients showed a median time to grafting of 11 days, with grafting achieved as early as five days, 25% of patients grafted within seven days, and 72% grafted within 14 days.The study is ongoing, with the full dataset expected this year.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","AVH.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626200489","title":"Avita Medical Secures Nearly $26 Million US Government Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2626200489","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626200489?lang=en_us&edition=fundamental","pubTime":"2026-04-09 06:03","pubTimestamp":1775685826,"startTime":"0","endTime":"0","summary":"Avita Medical  entered a 10-year agreement potentially worth up to $25.5 million with the Biomedical Advanced Research and Development Authority , part of the US Department of Health and Human Services, to strengthen response capabilities for large-scale burn incidents under project BioShield, according to a Thursday statement from the company.The agreement focuses on keeping ready-to-use inventory of the Recell wound care system to ensure emergency response capacity, and maintaining efficient logistics to support rapid emergency response readiness, the company said.The contract provides about $4 million in expected revenue and includes purchase options that BARDA may exercise over the contract term.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AVH.AU","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624552231","title":"Avita Medical Files Shelf Registration Statement With US SEC; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624552231","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624552231?lang=en_us&edition=fundamental","pubTime":"2026-04-01 08:34","pubTimestamp":1775003685,"startTime":"0","endTime":"0","summary":"Avita Medical  said it has filed a shelf registration statement with the US Securities and Exchange Commission , allowing it to offer and sell up to $200 million in aggregate of common stock, preferred stock, warrants, or units in one or more offerings over time, according to a Wednesday Australian bourse filing.The company said filing a shelf registration statement is common practice for US public companies registered with the US SEC, with statements expiring after three years, requiring companies to file a new statement every three years.Avita Medical said it currently has no plans to offer securities covered by the shelf registration statement, and it is possible that no securities will be offered or sold through it.The company's shares rose almost 3% in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","AVH.AU","BK7508","SEC.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}]}}